Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020

SELL
$72.92 - $102.01 $559,150 - $782,212
-7,668 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$55.75 - $92.75 $427,491 - $711,207
7,668 New
7,668 $667,000
Q1 2020

Apr 23, 2020

SELL
$37.9 - $104.44 $24,559 - $67,677
-648 Closed
0 $0
Q3 2019

Oct 18, 2019

BUY
$90.37 - $122.49 $23,225 - $31,479
257 Added 65.73%
648 $59,000
Q2 2019

Aug 01, 2019

BUY
$89.51 - $118.04 $17,096 - $22,545
191 Added 95.5%
391 $47,000
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $12,396 - $19,300
200 New
200 $17,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.